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Abstract 
Antibiotic resistance has been described as an ‘apocalyptic’ threat to human health. 
As resistance to antibiotics is common soon after they are introduced to clinical use, 
there is little investment in their development, thus prompting interest in complex 
natural products as antimicrobials. Honey has been used as a topical wound 
treatment throughout history, predominantly due to its antimicrobial activity. 
Manuka honey (from Leptospermum scoparium trees) has broad-spectrum 
antimicrobial activity effective against antibiotic resistant pathogens, such as 
ciprofloxacin-resistant Pseudomonas aeruginosa, and is currently approved as a 
wound treatment. Unlike traditional antibiotics, bacterial resistance to honey has 
not been reported, however honey remains underutilised in the clinic partly due to 
a lack of understanding of its mechanism of action. 
 
 
Through passaging experiments, it was found that honey resistance cannot be 
induced under conditions that rapidly induced resistance to antibiotics. This is due 
to the complex composition of honey, which is likely to have multiple modes of 
action, unlike traditional single target antibiotics. The mechanism of action of 
honey and its key components, methylglyoxal and sugar, was investigated using a 
transcriptomic approach in a model organism, P. aeruginosa. Results indicate that 
no single component of honey accounts for its total antimicrobial action and that 
honey causes DNA and oxidative damage, and affects pathways involved in cell 
motility, central carbon metabolism, and quorum sensing – explained only partially 
by its key components. 
viii  
Manuka honey uniquely upregulates genes involved in the explosive cell lysis 
process, an autolysis mechanism in P. aeruginosa. Honey also downregulates the 
expression of genes involved in maintaining the electron transport chain and causes 
protons to leak across biological membranes, ultimately collapsing the proton 
motive force. Flow cytometry data showed that treatment with manuka honey 
induces membrane depolarisation and permeabilisation in P. aeruginosa cells. This 
was confirmed by modelling membrane potential in liposomes and studying 
permeabilisation using electrical impedance spectroscopy of tethered lipid bilayer 
membranes. To investigate whether the membrane damaging action of honey could 
enhance the action of certain antibiotics, chequerboard assays were used to show 
that manuka honey acted synergistically with tetracyclines. Taken together, these 
data argue that manuka honey has multiple mechanisms of action, including the 
newly described membrane depolarising and permeabilising activity. This thesis 
contributes to the existing literature demonstrating the potent and unique 
antimicrobial activity of manuka honey which does not engender bacterial 
resistance, and supports its inclusion as part of the current array of wound 
treatments. 
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